Cancer
fromNews Center
1 day agoUnderstanding Treatment Response in High-Risk Bladder Cancer - News Center
High-risk non-muscle-invasive bladder cancer often recurs after BCG, and multi-omics profiling identifies molecular subtypes that may predict response to BCG.































